X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SANOFI INDIA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SANOFI INDIA ABBOTT INDIA/
SANOFI INDIA
 
P/E (TTM) x 32.9 30.0 109.8% View Chart
P/BV x 8.2 5.3 155.3% View Chart
Dividend Yield % 0.8 1.7 47.9%  

Financials

 ABBOTT INDIA   SANOFI INDIA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
SANOFI INDIA
Dec-16
ABBOTT INDIA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6,0154,560 131.9%   
Low Rs3,7074,400 84.3%   
Sales per share (Unadj.) Rs1,236.91,028.5 120.3%  
Earnings per share (Unadj.) Rs122.2129.0 94.7%  
Cash flow per share (Unadj.) Rs129.0186.0 69.4%  
Dividends per share (Unadj.) Rs35.0068.00 51.5%  
Dividend yield (eoy) %0.71.5 47.4%  
Book value per share (Unadj.) Rs521.2753.6 69.2%  
Shares outstanding (eoy) m21.2523.03 92.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.94.4 90.2%   
Avg P/E ratio x39.834.7 114.5%  
P/CF ratio (eoy) x37.724.1 156.5%  
Price / Book Value ratio x9.35.9 156.9%  
Dividend payout %28.652.7 54.3%   
Avg Mkt Cap Rs m103,296103,174 100.1%   
No. of employees `0003.03.6 81.6%   
Total wages/salary Rs m3,3703,592 93.8%   
Avg. sales/employee Rs Th8,891.86,537.7 136.0%   
Avg. wages/employee Rs Th1,140.0991.4 115.0%   
Avg. net profit/employee Rs Th878.3819.8 107.1%   
INCOME DATA
Net Sales Rs m26,28423,686 111.0%  
Other income Rs m504708 71.2%   
Total revenues Rs m26,78924,394 109.8%   
Gross profit Rs m3,6655,281 69.4%  
Depreciation Rs m1441,313 11.0%   
Interest Rs m815 54.0%   
Profit before tax Rs m4,0174,661 86.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4211,691 84.0%   
Profit after tax Rs m2,5962,970 87.4%  
Gross profit margin %13.922.3 62.5%  
Effective tax rate %35.436.3 97.5%   
Net profit margin %9.912.5 78.8%  
BALANCE SHEET DATA
Current assets Rs m14,44615,673 92.2%   
Current liabilities Rs m4,7256,678 70.8%   
Net working cap to sales %37.038.0 97.4%  
Current ratio x3.12.3 130.3%  
Inventory Days Days5176 67.6%  
Debtors Days Days2022 87.7%  
Net fixed assets Rs m1,1138,098 13.7%   
Share capital Rs m213230 92.3%   
"Free" reserves Rs m10,80817,088 63.2%   
Net worth Rs m11,07617,356 63.8%   
Long term debt Rs m00-   
Total assets Rs m16,24125,400 63.9%  
Interest coverage x497.0311.7 159.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.60.9 173.6%   
Return on assets %16.011.8 136.5%  
Return on equity %23.417.1 137.0%  
Return on capital %36.326.9 134.9%  
Exports to sales %0.624.5 2.5%   
Imports to sales %12.628.0 45.2%   
Exports (fob) Rs m1625,801 2.8%   
Imports (cif) Rs m3,3226,627 50.1%   
Fx inflow Rs m2687,145 3.8%   
Fx outflow Rs m3,9276,846 57.4%   
Net fx Rs m-3,659299 -1,223.9%   
CASH FLOW
From Operations Rs m2,5143,226 77.9%  
From Investments Rs m-800-1,555 51.4%  
From Financial Activity Rs m-803-1,818 44.2%  
Net Cashflow Rs m912-147 -620.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 7.9 14.4 54.9%  
FIIs % 0.1 14.6 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.5 162.9%  
Shareholders   18,270 15,184 120.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TTK HEALTHCARE  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 23, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - TTK HEALTHCARE COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS